Dr. Ann Snyder, M.D.
What this data tells you about Dr. Snyder
Dr. Ann Snyder is a family medicine in McKinney, TX, with 19 years in practice. Based on federal Medicare data, Dr. Snyder performed 9,229 Medicare services across 3,361 unique beneficiaries.
Between the years covered by Open Payments, Dr. Snyder received a total of $4,941 from 59 pharmaceutical and/or device companies across 323 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Snyder is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,961 | $18 | $42 |
| Office visit, established patient (30-39 min) | 1,159 | $88 | $170 |
| Blood draw (venipuncture) | 698 | $8 | $18 |
| Automated urinalysis | 566 | $2 | $15 |
| Urine microalbumin (protein) analysis | 402 | $6 | $20 |
| Creatinine test (kidney function) | 402 | $5 | $20 |
| Annual wellness visit, follow-up | 264 | $124 | $145 |
| Annual depression screening | 203 | $18 | $25 |
| Detection test by immunoassay with direct visual observation for influenza virus | 153 | $16 | $48 |
| Hemoglobin A1c test (diabetes monitoring) | 141 | $10 | $35 |
| Flu vaccine administration | 137 | $30 | $44 |
| Flu vaccine, high-dose | 136 | $72 | $98 |
| Drug injection, under skin or into muscle | 134 | $10 | $45 |
| Office visit, established patient (20-29 min) | 123 | $62 | $125 |
| Annual alcohol misuse screening, 5 to 15 minutes | 118 | $18 | $50 |
| Office visit, established patient, complex (40-54 min) | 92 | $125 | $220 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 82 | $35 | $105 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 79 | $16 | $65 |
| Bone density scan (DEXA) | 64 | $36 | $375 |
| Electrocardiogram (EKG), 12-lead | 50 | $10 | $55 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 50 | $1 | $10 |
| Steroid injection (triamcinolone) | 44 | $1 | $15 |
| New patient office visit (45-59 min) | 33 | $113 | $260 |
| Pneumonia vaccine administration | 30 | $30 | $44 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 23 | $282 | $378 |
| Administration of vaccine | 22 | $12 | $38 |
| Assessment of emotional or behavioral problems | 22 | $3 | $25 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 17 | $158 | $186 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 13 | $8 | $55 |
| Office visit, established patient (10-19 min) | 11 | $43 | $105 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Snyder is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 13%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Snyder experienced with denosumab injection (prolia/xgeva)?
Does Dr. Snyder receive payments from pharmaceutical companies?
How do Dr. Snyder's costs compare to other family medicines in McKinney?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology